Filters
Sort results
Reset
Apply
Cat No. | Products Name | Name | Previous Name | Target | Format | Options | Order | quote |
|---|---|---|---|---|---|---|---|---|
Pre-Made Abagovomab biosimilar, Whole Mab: Anti-CA125/MUC16 therapeutic antibody |
Abagovomab |
NA |
CA125/MUC16 |
Whole mAb |
||||
Pre-Made Abelacimab biosimilar, Whole mAb, Anti-F11 Antibody: Anti-FXI/PTA therapeutic antibody |
Abelacimab |
NA |
F11 |
Whole mAb |
||||
Pre-Made Abituzumab biosimilar, Whole mAb, Anti-ITGAV Antibody: Anti-CD51/MSK8/VNRA/VTNR therapeutic antibody |
Abituzumab |
NA |
ITGAV |
Whole mAb |
||||
Pre-Made Abrezekimab biosimilar, Fab, Anti-IL13 Antibody: Anti-IL-13/P600 therapeutic antibody |
Abrezekimab |
NA |
IL13 |
Fab |
||||
Pre-Made Abrilumab biosimilar, Whole mAb, Anti-¦Á4¦Â7/Integrin alpha 4 beta 7 Antibody: Anti-LPAM?1 therapeutic antibody |
Abrilumab |
NA |
α4β7/Integrin alpha 4 beta 7 |
Whole mAb |
||||
Pre-Made Acapatamab biosimilar, Bispecific scFv, Anti-FOLH1/GCPII;CD3E Antibody: Anti-FGCP/GCP2/NAALAD1/PSM/PSMA/mGCP;T3E/TCRE/IMD18 therapeutic antibody |
Acapatamab |
NA |
FOLH1/GCPII,CD3E |
Bispecific scFv |
||||
Pre-Made Acasunlimab biosimilar, Bispecific mAb, Anti-B7-H/B7H1/PDCD1L1/PDCD1LG1/PDL1/hPD-L1;ILA/4-1BB/CDw137 Antibod: Anti-CD274/PD-L1;TNFRSF9/CD137 therapeutic antibody |
Acasunlimab |
NA |
CD274/PD-L1,TNFRSF9/CD137 |
Bispecific mAb |
||||
Pre-Made Actoxumab biosimilar, Whole Mab: Anti-Toxin A therapeutic antibody |
Actoxumab |
NA |
Toxin A |
Whole mAb |
||||
Pre-Made Adalimumab biosimilar, Whole mAb, Anti-TNFA/TNF Antibody: Anti-DIF/TNFSF2/TNLG1F therapeutic antibody |
Adalimumab |
NA |
TNFA/TNF |
Whole mAb |
||||
Pre-Made Adebrelimab biosimilar, Whole mAb, Anti-CD274/PD-L1 Antibody: Anti-B7-H/B7H1/PDCD1L1/PDCD1LG1 therapeutic antibody |
Adebrelimab |
NA |
CD274/PD-L1 |
Whole mAb |
||||
Pre-Made Aducanumab biosimilar, Whole mAb, Anti-APP Antibody: Anti-AAA/AD1/PN2/ABPP/CVAP/ABETA/PN-II/preA4/CTFgamma therapeutic antibody |
Aducanumab |
NA |
APP |
Whole mAb |
||||
Pre-Made Afasevikumab biosimilar, Whole mAb, Anti-IL17A/IL17 Antibody: Anti-CTLA-8/CTLA8A/ILA17 therapeutic antibody |
Afasevikumab |
NA |
IL17A/IL17 |
Whole mAb |
||||
Pre-Made Afutuzumab biosimilar, Whole mAb, Anti-MS4A1/CD20 Antibody: Anti-B1/Bp35/CVID5/FMC7/LEU-16/S7 therapeutic antibody |
Afutuzumab |
Obinutuzumab |
MS4A1/CD20 |
Whole mAb |
||||
Pre-Made Alacizumab biosimilar, di-Fab, Anti-KDR Antibody: Anti-FLK1/CD309/VEGFR/VEGFR2 therapeutic antibody |
Alacizumab |
NA |
KDR |
di-Fab |
||||
Pre-Made Alemtuzumab biosimilar, Whole mAb, Anti-CD52 Antibody: Anti-HE5/CDW52/EDDM5 therapeutic antibody |
Alemtuzumab |
NA |
CD52 |
Whole mAb |
||||
Pre-Made Alirocumab biosimilar, Whole mAb, Anti-PCSK9 Antibody: Anti-FH3/FHCL3/HCHOLA3/LDLCQ1/NARC-1/NARC1/PC9 therapeutic antibody |
Alirocumab |
NA |
PCSK9 |
Whole mAb |
||||
Pre-Made Alomfilimab biosimilar, Whole mAb, Anti-ICOS Antibody: Anti-AILIM/CD278/CVID1 therapeutic antibody |
Alomfilimab |
NA |
ICOS |
Whole mAb |
||||
Pre-Made Alnuctamab biosimilar, Bispecific mAb with Domain Crossover, Anti-TNFRSF17;CD3E Antibody: Anti-BCM/BCMA/CD269/TNFRSF13A;T3E/TCRE/IMD18 therapeutic antibody |
Alnuctamab |
NA |
TNFRSF17,CD3E |
Bispecific mAb with Domain Crossover |
||||
Pre-Made Alsevalimab biosimilar, Whole mAb, Anti-VTCN1 Antibody: Anti-B7-H4/B7H4/B7S1/B7X/B7h.5/PRO1291/VCTN1 therapeutic antibody |
Alsevalimab |
NA |
VTCN1 |
Whole mAb |
||||
Pre-Made Amatuximab biosimilar, Whole mAb, Anti-MSLN Antibody: Anti-MPF/SMRP therapeutic antibody |
Amatuximab |
NA |
MSLN |
Whole mAb |
